RSS
3 Jun 2022

BioVaxys and The Ohio State University Progress Pan-Sarbecovirus Vaccine Research Program

Author: admintech | Filed under: Press Release

Pan-Sarbecovirus Vaccines Identified by WHO as a Critical Need VANCOUVER, BC, June 3, 2022 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (“BioVaxys” or “Company”) announced today that The Ohio State University (“Ohio State”), its research collaborator…

This entry was posted on Friday, June 3rd, 2022 at 7:16 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»